Engineered Antibodies for immunoPET: Probes for Profiling Tumors and Immune Responses

Abstract Archives of the RSNA, 2016

RC811B

Friday, Dec. 2 8:30AM - 10:00AM Room: E353A

FDA Discussions may include off-label uses.

Anna M. Wu, PhD, Los Angeles, CA, (awu@mednet.ucla.edu ) (Presenter) Stockholder, ImaginAb, Inc; Consultant, ImaginAb, Inc; Consultant, Avidity NanoMedicines, LLC;

LEARNING OBJECTIVES

1) Identify key properties of antibodies that can be modified/improved to produce probes optimized for in vivo imaging. 2) Discuss applications of new immunoPET tracers to address challenges in oncology and immunology. 3) Describe the process and potential of translating immunoPET probes into clinical use.